Recurrent genetic defects on chromosome 7q in myeloid neoplasms

Leukemia

Volumn 28, Issue 6, 2014, Pages 1348-1351

  Hosono, N ^a,b   Makishima, H ^a   Jerez, A ^a   Yoshida, K ^c,d   Przychodzen, B ^a   Mcmahon, S ^e   Shiraishi, Y ^f   Chiba, K ^f   Tanaka, H ^f   Miyano, S ^f   Sanada, M ^c,d   Gomez Segui I ^a   Verma, A K ^g   Mcdevitt, M A ^h   Sekeres, M A ^a   Ogawa, S ^c,d   Maciejewski, J P ^a  

^a TAUSSIG CANCER INSTITUTE   (United States)

^b UNIVERSITY OF FUKUI   (Japan)

^c GRADUATE SCHOOL OF MEDICINE   (Japan)

^d KYOTO UNIVERSITY   (Japan)

^e CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f UNIVERSITY OF TOKYO   (Japan)

^g ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^h JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HISTONE METHYLTRANSFERASE; SMALL NUCLEAR RIBONUCLEOPROTEIN; TRANSCRIPTION FACTOR EZH2;

ACUTE GRANULOCYTIC LEUKEMIA; CANCER SURVIVAL; CFTR GENE; CHROMOSOME 7Q; CHROMOSOME DELETION; CONTROLLED STUDY; CUL1 GENE; CUX1 GENE; DIPLOIDY; DYNC1L1 GENE; ENZYME ACTIVITY; EXON; FRAMESHIFT MUTATION; GENE EXPRESSION; GENE INACTIVATION; GENE LOCUS; GENETIC DISORDER; GENETIC RISK; HAPLOIDY; HAPLOINSUFFICIENCY; HETEROZYGOSITY LOSS; HUMAN; KARYOTYPING; LETTER; LOSS OF FUNCTION MUTATION; LUC7L2 GENE; MONOSOMY 7; MYELODYSPLASTIC SYNDROME; MYELOID LEUKEMIA; MYELOPROLIFERATIVE NEOPLASM; NONSENSE MUTATION; NRCAM GENE; ONCOGENE; PATHOGENESIS; PLXNA4 GENE; PRIORITY JOURNAL; SOMATIC MUTATION; TRANSCRIPTION FACTOR EZH2 GENE; UNIPARENTAL DISOMY; WILD TYPE; CANCER PROGNOSIS; METAPHASE; PRIMARY ACUTE MYELOID LEUKEMIA; RECURRENT DISEASE;

CHROMOSOMES, HUMAN, PAIR 7; HOMEODOMAIN PROTEINS; HUMANS; KARYOTYPING; LEUKEMIA, MYELOID, ACUTE; LOSS OF HETEROZYGOSITY; MYELODYSPLASTIC SYNDROMES; MYELOPROLIFERATIVE DISORDERS; NUCLEAR PROTEINS; POLYCOMB REPRESSIVE COMPLEX 2; POLYMORPHISM, SINGLE NUCLEOTIDE; PROGNOSIS; REPRESSOR PROTEINS; RNA-BINDING PROTEINS; SURVIVAL RATE;

EID: 84902081732     PISSN: 08876924     EISSN: 14765551     Source Type: Journal    
DOI: 10.1038/leu.2014.25     Document Type: Letter

References (15)

1. Ernst T, Chase AJ, Score J, Hidalgo-Curtis CE, Bryant C, Jones AV et al. Inactivating mutations of the histone methyltransferase gene EZH2 in myeloid disorders. Nat Genet 2010; 42: 722-726.
2. Makishima H, Jankowska AM, Tiu RV, Szpurka H, Sugimoto Y, Hu Z et al. Novel homo-And hemizygous mutations in EZH2 in myeloid malignancies. Leukemia 2010; 24: 1799-1804.
3. Nikoloski G, Langemeijer SM, Kuiper RP, Knops R, Massop M, Tonnissen ER et al. Somatic mutations of the histone methyltransferase gene EZH2 in myelodysplastic syndromes. Nat Genet 2010; 42: 665-667.
4. Jerez A, Sugimoto Y, Makishima H, Verma A, Jankowska AM, Przychodzen B et al. Loss of heterozygosity in 7q myeloid disorders: Clinical associations and genomic pathogenesis. Blood 119: 6109-6117.
5. Gomez-Segui I, Makishima H, Jerez A, Yoshida K, Przychodzen B, Miyano S et al. Novel recurrent mutations in the RAS-LIKE GTP-Binding gene RIT1 in myeloid malignancies. Leukemia 2013; 27: 1943-1946.
6. Kipreos ET, Lander LE, Wing JP, He WW, Hedgecock EM. cul-1 is required for cell cycle exit in C. elegans and identifies a novel gene family. Cell 1996; 85: 829-839. (Pubitemid 26192134)
7. Marti A, Wirbelauer C, Scheffner M, Krek W. Interaction between ubiquitin-protein ligase SCFSKP2 and E2F-1 underlies the regulation of E2F-1 degradation. Nat Cell Biol 1999; 1: 14-19. (Pubitemid 129495004)
8. Tamagnone L, Artigiani S, Chen H, He Z, Ming GI, Song H et al. Plexins are a large family of receptors for transmembrane, secreted, and GPI-Anchored semaphorins in vertebrates. Cell 1999; 99: 71-80. (Pubitemid 29468631)
9. Khan SN, Jankowska AM, Mahfouz R, Dunbar AJ, Sugimoto Y, Hosono N et al. Multiple mechanisms deregulate EZH2 and histone H3 lysine 27 epigenetic changes in myeloid malignancies. Leukemia 2013; 27: 1301-1309.
10. Howell VM, Jones JM, Bergren SK, Li L, Billi AC, Avenarius MR et al. Evidence for a direct role of the disease modifier SCNM1 in splicing. Hum Mol Genet 2007; 16: 2506-2516. (Pubitemid 47500636)
11. Singh H, Lane AA, Correll M, Przychodzen B, Sykes DB, Stone RM et al. Putative RNA-splicing gene LUC7L2 on 7q34 represents a candidate gene in pathogenesis of myeloid malignancies. Blood Cancer J 2013; 3: E117.
12. Nepveu A. Role of the multifunctional CDP/Cut/Cux homeodomain transcription factor in regulating differentiation, cell growth and development. Gene 2001; 270: 1-15. (Pubitemid 32525797)
13. Hulea L, Nepveu A. CUX1 transcription factors: From biochemical activities and cell-based assays to mouse models and human diseases. Gene 2012; 497: 18-26.
14. Thoennissen NH, Lasho T, Thoennissen GB, Ogawa S, Tefferi A, Koeffler HP. Novel CUX1 missense mutation in association with 7q-At leukemic transformation of MPN. Am J Hematol 2011; 86: 703-705.
15. Cadieux C, Fournier S, Peterson AC, Bedard C, Bedell BJ, Nepveu A. Transgenic mice expressing the p75 CCAAT-displacement protein/Cut homeobox isoform develop a myeloproliferative disease-like myeloid leukemia. Cancer Res 2006; 66: 9492-9501. (Pubitemid 44623647)